Ana M.
Ana M. Balasoiu, Akron, OH US
Patent application number | Description | Published |
---|---|---|
20100212744 | SELF-ACTING SELF-CIRCULATING FLUID SYSTEM WITHOUT EXTERNAL PRESSURE SOURCE AND USE IN BEARING SYSTEM - The invention includes a method for continually circulating a fluid in a system, in the absence of an external pumping mechanism, by providing a fluid, an active space capable of generating a higher pressure zone and causing a contiguous lower pressure zone, a passive space, and a porous medium disposed between the active space and the passive space, and generating a pressure differential relationship between the active space and the passive space causing the fluid to circulate freely in both directions between the active space and the passive space, across the porous medium, without the aid of an external pumping system, such that the fluid circulation defines a self-acting self-circulating fluid system, and to the system created thereby. | 08-26-2010 |
Ana M. Calvo-Byrd, Dekalb, IL US
Patent application number | Description | Published |
---|---|---|
20140134671 | EFFECTS OF ALTERATION OF EXPRESSION OF THE MtfA GENE AND ITS HOMOLOGS ON THE PRODUCTION OF FUNGAL SECONDARY METABOLITES - Many fungal secondary metabolites are of industrial interest, such as antibiotics, while others are undesirable compounds such as mycotoxins. Overexpression of mtfA enhances production of fungal compounds with applications in the medical field, and overexpression or impaired mtfA expression decreases the production of compounds that negatively affect health/agriculture/economy such as mycotoxins. | 05-15-2014 |
20140134742 | EFFECTS OF ALTERATION OF EXPRESSION OF THE MtfA GENE AND ITS HOMOLOGS ON THE PRODUCTION OF FUNGAL SECONDARY METABOLITES - Many fungal secondary metabolites are of industrial interest, such as antibiotics, while others are undesirable compounds such as mycotoxins. Overexpression of mtfA enhances production of fungal compounds with applications in the medical field, and overexpression or impaired mtfA expression decreases the production of compounds that negatively affect health/agriculture/economy such as mycotoxins. | 05-15-2014 |
Ana M. Chamoun-Emanuelli, College Station, TX US
Patent application number | Description | Published |
---|---|---|
20140328795 | VIRUCIDAL SMALL MOLECULE AND USES THEREOF - In an embodiment of the present disclosure there is provided a method of inactivating enveloped DNA virus particles in a biological sample. In an embodiment, such a method comprises contacting the biological sample with an effective amount of an antiviral composition comprising PD 404,182 In some embodiments, the DNA virus is the Herpes Simplex virus-1 (HSV-1) or the Herpes Simplex Virus-2 (HSV-2). In another embodiment of the present disclosure, there is provided a method of treating, preventing, or reducing a viral infection caused by an enveloped DNA virus in a subject in need thereof. In yet another embodiment, there is provided a method of preventing transmission of a viral infection to a subject in need thereof. In an embodiment, such a method comprises contacting a mucus membrane of the subject with a topical formulation comprising an effective amount of PD 404,182 in combination with a pharmaceutically acceptable carrier | 11-06-2014 |
Ana M. Gonzalez, Cambridge, MA US
Patent application number | Description | Published |
---|---|---|
20150368349 | Anti-GITR Antibodies and Methods of Use Thereof - The present disclosure provides antibodies that specifically bind to human glucocorticoid-induced TNFR family related receptor (GITR) and compositions comprising such antibodies. In a specific aspect, the antibodies specifically bind to human GITR and modulate GITR activity, e.g., enhance, activate or induce GITR activity, utilizing such antibodies. The present disclosure also provides methods for treating disorders, such as cancer and infectious diseases, by administering an antibody that specifically binds to human GITR and modulates GITR activity e.g., enhances, activates or induces GITR activity. | 12-24-2015 |
Ana M. Pricochi, Bucharest RO
Patent application number | Description | Published |
---|---|---|
20140108656 | Load Balancing in Handwritten Signature Authentication Systems - Described systems and methods allow a biometric authentication system to process authentication requests, such as requests to authenticate handwritten signatures, received from a plurality of client systems, each covered by a service level agreement (SLA). The biometric authentication system includes a load balancer configured to distribute authentication tasks to a plurality of worker machines. In some embodiments, task distribution is performed according to an ability of each worker to process urgent tasks, to an ability of each worker to process non-urgent tasks, and further according to a relationship between a count of urgent requests and a count of non-urgent requests received by the biometric authentication system. | 04-17-2014 |
Ana M. Rivera, Henderson, NV US
Patent application number | Description | Published |
---|---|---|
20160120323 | SCREENING DEVICE - A screening device detachably joins with furniture, such as a lounge chair to screen against the elements by pivoting between an expanded position for screening, and a retracted position for stowing. A plurality of support members form the structural support of the device and carry a canopy. A strut and an adjacently attached disc extend from the terminal ends of each support member. A cog wheel attaches to the discs for regulating movement of the support members, and includes a central axle and peripheral rods that extend from one side of the cog wheel. The central axle passes through a central aperture. Each peripheral rod passes through a corresponding peripheral aperture in the discs. A spring biases the cog wheel into engagement with the discs to restrain the support members. A release member presses against the spring to release the support members for movement between positions. | 05-05-2016 |